Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Modulation of lung cancer growth arrest and apoptosis by Phellinus Linteus.

Guo J, Zhu T, Collins L, Xiao ZX, Kim SH, Chen CY.

Mol Carcinog. 2007 Feb;46(2):144-54.

PMID:
17131292
2.

The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover.

Chang L, Kamata H, Solinas G, Luo JL, Maeda S, Venuprasad K, Liu YC, Karin M.

Cell. 2006 Feb 10;124(3):601-13.

3.

Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch.

Gao M, Labuda T, Xia Y, Gallagher E, Fang D, Liu YC, Karin M.

Science. 2004 Oct 8;306(5694):271-5. Epub 2004 Sep 9.

4.

A JNK-dependent pathway is required for TNFalpha-induced apoptosis.

Deng Y, Ren X, Yang L, Lin Y, Wu X.

Cell. 2003 Oct 3;115(1):61-70.

5.

Bcl-2, via its BH4 domain, blocks apoptotic signaling mediated by mitochondrial Ras.

Denis GV, Yu Q, Ma P, Deeds L, Faller DV, Chen CY.

J Biol Chem. 2003 Feb 21;278(8):5775-85. Epub 2002 Dec 10.

6.

Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides.

Wasser SP.

Appl Microbiol Biotechnol. 2002 Nov;60(3):258-74. Epub 2002 Sep 10. Review.

PMID:
12436306
7.

Doxorubicin enhances TRAIL-induced apoptosis in prostate cancer.

Wu XX, Kakehi Y, Mizutani Y, Kamoto T, Kinoshita H, Isogawa Y, Terachi T, Ogawa O.

Int J Oncol. 2002 May;20(5):949-54.

PMID:
11956588
8.

Activation of caspase-3 in renal cell carcinoma cells by anthracyclines or 5-fluorouracil.

Wu XX, Kakehi Y, Mizutani Y, Lu J, Terachi T, Ogawa O.

Int J Oncol. 2001 Jul;19(1):19-24.

PMID:
11408917
9.

Anticancer agents sensitize tumor cells to tumor necrosis factor-related apoptosis-inducing ligand-mediated caspase-8 activation and apoptosis.

Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche-Boitrel MT.

Cancer Res. 2001 Feb 15;61(4):1645-51.

10.

Signal transduction by the JNK group of MAP kinases.

Davis RJ.

Cell. 2000 Oct 13;103(2):239-52. Review. No abstract available.

11.

Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines.

Yamanaka T, Shiraki K, Sugimoto K, Ito T, Fujikawa K, Ito M, Takase K, Moriyama M, Nakano T, Suzuki A.

Hepatology. 2000 Sep;32(3):482-90.

PMID:
10960439
12.

Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.

Mizutani Y, Yoshida O, Miki T, Bonavida B.

Clin Cancer Res. 1999 Sep;5(9):2605-12.

13.

Mushrooms, tumors, and immunity.

Borchers AT, Stern JS, Hackman RM, Keen CL, Gershwin ME.

Proc Soc Exp Biol Med. 1999 Sep;221(4):281-93. Review.

PMID:
10460691
14.

The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis.

Han SB, Lee CW, Jeon YJ, Hong ND, Yoo ID, Yang KH, Kim HM.

Immunopharmacology. 1999 Feb;41(2):157-64.

PMID:
10102797
15.

Chemotherapy augments TRAIL-induced apoptosis in breast cell lines.

Keane MM, Ettenberg SA, Nau MM, Russell EK, Lipkowitz S.

Cancer Res. 1999 Feb 1;59(3):734-41.

16.

Signaling pathway activated during apoptosis of the prostate cancer cell line LNCaP: overexpression of caspase-7 as a new gene therapy strategy for prostate cancer.

Marcelli M, Cunningham GR, Walkup M, He Z, Sturgis L, Kagan C, Mannucci R, Nicoletti I, Teng B, Denner L.

Cancer Res. 1999 Jan 15;59(2):382-90.

17.
18.

Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP.

Marcelli M, Cunningham GR, Haidacher SJ, Padayatty SJ, Sturgis L, Kagan C, Denner L.

Cancer Res. 1998 Jan 1;58(1):76-83.

19.

Caspases: intracellular signaling by proteolysis.

Salvesen GS, Dixit VM.

Cell. 1997 Nov 14;91(4):443-6. Review. No abstract available.

20.

Cross-resistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases).

Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K, Debatin KM.

Blood. 1997 Oct 15;90(8):3118-29.

Supplemental Content

Support Center